Align Technology (ALGN) Stock Forecast, Price & News

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ALGN shares.
View ALGN analyst ratings or view top-rated stocks.

10 brokers have issued 12-month price targets for Align Technology's shares. Their ALGN share price forecasts range from $225.00 to $390.00. On average, they anticipate the company's share price to reach $347.78 in the next twelve months. This suggests a possible upside of 21.9% from the stock's current price.
View analysts price targets for ALGN or view top-rated stocks among Wall Street analysts.

Align Technology's stock was trading at $210.90 at the start of the year. Since then, ALGN stock has increased by 35.3% and is now trading at $285.39.
View the best growth stocks for 2023 here.

Align Technology saw a decline in short interest in May. As of May 15th, there was short interest totaling 1,830,000 shares, a decline of 20.8% from the April 30th total of 2,310,000 shares. Based on an average daily trading volume, of 833,500 shares, the short-interest ratio is currently 2.2 days. Currently, 2.6% of the shares of the company are sold short.
View Align Technology's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 26th 2023.
View our ALGN earnings forecast.

Align Technology, Inc. (NASDAQ:ALGN) posted its earnings results on Tuesday, October, 26th. The medical equipment provider reported $2.87 earnings per share for the quarter, beating analysts' consensus estimates of $2.60 by $0.27. The medical equipment provider earned $1.02 billion during the quarter, compared to analyst estimates of $977.81 million. Align Technology had a trailing twelve-month return on equity of 11.18% and a net margin of 8.51%. The firm's revenue for the quarter was up 38.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.76 EPS.
Read the conference call transcript.

ETFs with the largest weight of Align Technology (NASDAQ:ALGN) stock in their portfolio include First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), UPHOLDINGS Compound Kings ETF (KNGS), First Trust Indxx Medical Devices ETF (MDEV), AI Quality Growth ETF (AQGX), Alpha Intelligent - Large Cap Growth ETF (AILG), First Trust Innovation Leaders ETF (ILDR), First Trust NASDAQ-100 Ex-Technology Sector Index Fund (QQXT) and Invesco S&P 500 Equal Weight Health Care ETF (RYH).

Align Technology issued an update on its second quarter 2023 earnings guidance on Thursday, April, 27th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $980.00M-$1.00 billion, compared to the consensus revenue estimate of $951.31 million.

346 employees have rated Align Technology Chief Executive Officer Joe Hogan on Glassdoor.com. Joe Hogan has an approval rating of 97% among the company's employees. This puts Joe Hogan in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), PayPal (PYPL), Micron Technology (MU), Adobe (ADBE), Visa (V), Salesforce (CRM), Mastercard (MA) and Tesla (TSLA).

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Align Technology's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.02%), State Street Corp (3.91%), Sands Capital Management LLC (3.00%), Wellington Management Group LLP (2.21%), Geode Capital Management LLC (2.07%) and Price T Rowe Associates Inc. MD (1.85%). Insiders that own company stock include Andrea Lynn Saia, C Raymond Larkin Jr, C Raymond Larkin, Jr, Emory Wright, George J Morrow, John Morici, Joseph Lacob, Joseph M Hogan, Julie Ann Coletti, Julie Tay, Kevin C Burns, Robert E Fitzgerald, Simon Beard, Stuart A Hockridge, Thomas M Prescott, Warren S Thaler, Yuval Shaked and Zelko Relic.
View institutional ownership trends.

Shares of ALGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALGN stock can currently be purchased for approximately $285.39.

Align Technology (NASDAQ:ALGN) has a market capitalization of $21.84 billion and generates $3.73 billion in revenue each year. The medical equipment provider earns $361.57 million in net income (profit) each year or $4.05 on an earnings per share basis.

The company employs 23,165 workers across the globe.

Align Technology's mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The official website for the company is www.aligntech.com. The medical equipment provider can be reached via phone at (602) 742-2000, via email at align@ethoscommunication.com, or via fax at 408-470-1010.